CytoDyn (CYDY) Cash from Financing Activities (2009 - 2026)
CytoDyn (CYDY) reported Cash from Financing Activities of $12.23 million for fiscal Q1 2027 (quarter ended Aug 31, 2026), compared with -$121,000 a year earlier and up 982.6% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Over the twelve months ended Aug 31, 2026, CytoDyn's Cash from Financing Activities came in at $29.56 million; for FY2026 (ended May 31, 2026), it was $17.2 million, up 58.5% from FY2025.
- Cash from Financing Activities has a five-year compound annual growth rate of -34.0% (FY2021 to FY2026).
- By fiscal year, Cash from Financing Activities came in at $10.85 million in FY2025 (-7.6%), $11.75 million in FY2024 (-60.7%), $29.93 million in FY2023 (-37.7%) and $48.01 million in FY2022 (-65.0%).
- Five-year quarterly Cash from Financing Activities spans a low of -$121,000 in fiscal Q1 2026 and a high of $31.23 million in fiscal Q2 2022.
- The high point for year-over-year Cash from Financing Activities in five years was fiscal Q3 2023 (growth of 223.5%); the low point was fiscal Q3 2025 (a decline of 99.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | CytoDyn | 334.50 Mn | 285.65 Mn | - | 12.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 12.23 Mn |
| May 31, 2026 | 1.13 Mn |
| Feb 28, 2026 | 16.19 Mn |
| Aug 31, 2025 | -121,000.00 |
| May 31, 2025 | 1.17 Mn |
| Feb 28, 2025 | 21,000.00 |
| Aug 31, 2024 | 9.67 Mn |
| May 31, 2024 | 3.44 Mn |
| Feb 29, 2024 | 3.63 Mn |
| Nov 30, 2023 | 654,000.00 |
| Aug 31, 2023 | 4.02 Mn |
| May 31, 2023 | 1.35 Mn |
| Feb 28, 2023 | 14.73 Mn |
| Nov 30, 2022 | 2.33 Mn |
| Aug 31, 2022 | 11.52 Mn |
| May 31, 2022 | 7.88 Mn |
| Feb 28, 2022 | 4.55 Mn |
| Nov 30, 2021 | 31.23 Mn |
| Aug 31, 2021 | 4.35 Mn |
| May 31, 2021 | 52.48 Mn |
API Access
CytoDyn Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();